Jules I. Schwartz

2.7k total citations
81 papers, 2.1k citations indexed

About

Jules I. Schwartz is a scholar working on Pharmacology, Pharmacology and Molecular Biology. According to data from OpenAlex, Jules I. Schwartz has authored 81 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pharmacology, 25 papers in Pharmacology and 17 papers in Molecular Biology. Recurrent topics in Jules I. Schwartz's work include Pharmacogenetics and Drug Metabolism (24 papers), Inflammatory mediators and NSAID effects (21 papers) and Asthma and respiratory diseases (9 papers). Jules I. Schwartz is often cited by papers focused on Pharmacogenetics and Drug Metabolism (24 papers), Inflammatory mediators and NSAID effects (21 papers) and Asthma and respiratory diseases (9 papers). Jules I. Schwartz collaborates with scholars based in United States, Belgium and France. Jules I. Schwartz's co-authors include David L. Ebel, Patrick Manning, Vanessa C. Williams, Richard M. Watson, Dorothy J. Margolskee, Paul M. O’Byrne, Barry J. Gertz, Kenneth C. Lasseter, Aimée Dallob and Inge De Lepeleire and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Jules I. Schwartz

75 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jules I. Schwartz United States 20 886 449 412 292 289 81 2.1k
P.J. De Schepper Belgium 20 682 0.8× 283 0.6× 325 0.8× 234 0.8× 72 0.2× 53 2.0k
Joseph Awad United States 27 662 0.7× 146 0.3× 333 0.8× 616 2.1× 276 1.0× 59 3.3k
N M Agrawal United States 10 2.2k 2.5× 304 0.7× 216 0.5× 342 1.2× 116 0.4× 24 2.8k
Shiro Ueda Japan 25 210 0.2× 354 0.8× 171 0.4× 266 0.9× 206 0.7× 111 2.7k
Sharon Arrol United Kingdom 29 1.1k 1.3× 399 0.9× 161 0.4× 837 2.9× 112 0.4× 43 4.7k
Hirotoshi Echizen Japan 28 387 0.4× 1.2k 2.7× 155 0.4× 311 1.1× 184 0.6× 100 3.0k
Yasuhiro Komatsu Japan 37 493 0.6× 801 1.8× 283 0.7× 85 0.3× 347 1.2× 181 4.3k
György Paragh Hungary 29 377 0.4× 144 0.3× 318 0.8× 207 0.7× 110 0.4× 136 2.7k
Marielle Kaplan Israel 32 310 0.3× 294 0.7× 199 0.5× 174 0.6× 221 0.8× 72 4.1k
Aimee Burr United States 7 2.1k 2.4× 284 0.6× 223 0.5× 340 1.2× 85 0.3× 10 2.7k

Countries citing papers authored by Jules I. Schwartz

Since Specialization
Citations

This map shows the geographic impact of Jules I. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jules I. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jules I. Schwartz more than expected).

Fields of papers citing papers by Jules I. Schwartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jules I. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jules I. Schwartz. The network helps show where Jules I. Schwartz may publish in the future.

Co-authorship network of co-authors of Jules I. Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Jules I. Schwartz. A scholar is included among the top collaborators of Jules I. Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jules I. Schwartz. Jules I. Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schwartz, Jules I., Mark Stroh, Bing Gao, et al.. (2009). Effects of Laropiprant, a Selective Prostaglandin D2 Receptor 1 Antagonist, on the Pharmacokinetics of Rosiglitazone. Cardiovascular Therapeutics. 27(4). 239–245. 4 indexed citations
2.
Schwartz, Jules I., Nancy Agrawal, Martin Wehling, et al.. (2008). Evaluation of the pharmacokinetics of digoxin in healthy subjects receiving etoricoxib. British Journal of Clinical Pharmacology. 66(6). 811–817. 12 indexed citations
3.
Schwartz, Jules I., Aimée Dallob, Patrick Larson, et al.. (2008). Comparative Inhibitory Activity of Etoricoxib, Celecoxib, and Diclofenac on COX‐2 Versus COX‐1 in Healthy Subjects. The Journal of Clinical Pharmacology. 48(6). 745–754. 35 indexed citations
4.
Agrawal, Nancy, Catherine Z. Matthews, Ralph S. Mazenko, et al.. (2003). Pharmacokinetics of Etoricoxib in Patients with Renal Impairment. The Journal of Clinical Pharmacology. 44(1). 48–58. 32 indexed citations
5.
Schwartz, Jules I., et al.. (2003). Effect of Rofecoxib on Prednisolone and Prednisone Pharmacokinetics in Healthy Subjects. The Journal of Clinical Pharmacology. 43(2). 187–192. 2 indexed citations
6.
Schwartz, Jules I., Arturo G. Porras, Peggy H. Wong, et al.. (2002). Effect of high-fat breakfast and moderate-fat evening meal on the pharmacokinetics of vardenafil, a potent, highly selective PDE-5 inhibitor for the treatment of erectile dysfunction. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(10). 1365–1366.
7.
Schwartz, Jules I., Nancy Agrawal, Peggy H. Wong, et al.. (2001). Lack of Pharmacokinetic Interaction between Rofecoxib and Methotrexate in Rheumatoid Arthritis Patients. The Journal of Clinical Pharmacology. 41(10). 1120–1130. 26 indexed citations
8.
Schwartz, Jules I., Marina De Smet, René Verbesselt, et al.. (2001). Effect of Rofecoxib on the Pharmacokinetics of Digoxin in Healthy Volunteers. The Journal of Clinical Pharmacology. 41(1). 107–112. 12 indexed citations
9.
Schwartz, Jules I.. (2000). Rofecoxib steady-state pharmacokinetics [PK] in moderate hepatic insufficiency patients (HI). The American Journal of Gastroenterology. 95(9). 2519–2519. 1 indexed citations
10.
Schwartz, Jules I., Catherine B. Chan, Saurabh Mukhopadhyay, et al.. (1999). Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans. Clinical Pharmacology & Therapeutics. 65(6). 653–660. 76 indexed citations
11.
Gharaibeh, Munir, Lisa Gillen, Barbara A. Osborne, Jules I. Schwartz, & Scott A. Waldman. (1998). Effect of Multiple Doses of Rifampin on the [14C N‐methyl] Erythromycin Breath Test in Healthy Male Volunteers. The Journal of Clinical Pharmacology. 38(6). 492–495. 28 indexed citations
12.
Schwartz, Jules I.. (1995). Searching for Magic Bullets: Orphan Drugs, Consumer Activism, and Pharmaceutical Development. American Journal of Health-System Pharmacy. 52(7). 766–768. 3 indexed citations
13.
Schwartz, Jules I., Oscar L. Laskin, Patricia M. Patterson, et al.. (1994). Pharmacodynamics of MK-0963, a new 5α-reductase inhibitor: Effects on serum androgen concentrations. Clinical Pharmacology & Therapeutics. 55(1). 50–54. 1 indexed citations
14.
Cheng, Haiyung, Jules I. Schwartz, Charles C. Lin, et al.. (1994). The bioavailability and nonlinear pharmacokinetics of MK‐679 in humans. Biopharmaceutics & Drug Disposition. 15(5). 409–418. 2 indexed citations
15.
Bachmann, K, et al.. (1988). Ethosuximide disposition kinetics in rats. Xenobiotica. 18(4). 373–380. 12 indexed citations
16.
Schwartz, Jules I., et al.. (1987). Theophylline-Induced Age-Related CNS Stimulation. Pediatric Asthma Allergy & Immunology. 1(3). 175–183. 7 indexed citations
17.
Bachmann, Kenneth, Jules I. Schwartz, Luis Jáuregui, Timothy J. Sullivan, & Mary Ellen Martin. (1987). Use of Three Probes to Assess the Influence of Sex on Hepatic Drug Metabolism. Pharmacology. 35(2). 88–93. 2 indexed citations
18.
Bachmann, Kenneth, et al.. (1984). The Effect of Erythromycin on the Disposition Kinetics of Warfarin. Pharmacology. 28(3). 171–176. 33 indexed citations
19.
Schwartz, Jules I., et al.. (1983). Impact of cimetidine on the pharmacokinetics of theophylline.. PubMed. 1(6). 534–8. 8 indexed citations
20.
Schwartz, Jules I., et al.. (1974). DML - An Interactive Data Management Language.. IFIP Congress. 1007–1011. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P.J. De Schepper Breakdown of academic impact, for papers by Joseph Awad Breakdown of academic impact, for papers by N M Agrawal Breakdown of academic impact, for papers by Shiro Ueda Breakdown of academic impact, for papers by Sharon Arrol Breakdown of academic impact, for papers by Hirotoshi Echizen Breakdown of academic impact, for papers by Yasuhiro Komatsu Breakdown of academic impact, for papers by György Paragh Breakdown of academic impact, for papers by Marielle Kaplan Breakdown of academic impact, for papers by Aimee Burr
Rankless by CCL
2026